Gilhus NE - Search Results

1

Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment.

Gilhus NE, Andersen H, Andersen LK, Boldingh M, Laakso S, Leopoldsdottir MO, Madsen S, Piehl F, Popperud TH, Punga AR, Schirakow L, Vissing J. Gilhus NE, et al. Eur J Neurol. 2024 May;31(5):e16229. doi: 10.1111/ene.16229. Epub 2024 Feb 6. Eur J Neurol. 2024. PMID: 38321574 Free PMC article. Review.

2

Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.

Mygland A, Tysnes OB, Matre R, Volpe P, Aarli JA, Gilhus NE. Mygland A, et al. Among authors: gilhus ne. Ann Neurol. 1992 Oct;32(4):589-91. doi: 10.1002/ana.410320419. Ann Neurol. 1992. PMID: 1333745

3

TNFA and TNFB polymorphisms in myasthenia gravis.

Skeie GO, Pandey JP, Aarli JA, Gilhus NE. Skeie GO, et al. Among authors: gilhus ne. Arch Neurol. 1999 Apr;56(4):457-61. doi: 10.1001/archneur.56.4.457. Arch Neurol. 1999. PMID: 10199335

4

Muscle autoantibodies in subgroups of myasthenia gravis patients.

Romi F, Skeie GO, Aarli JA, Gilhus NE. Romi F, et al. Among authors: gilhus ne. J Neurol. 2000 May;247(5):369-75. doi: 10.1007/s004150050604. J Neurol. 2000. PMID: 10896269

5

The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.

Romi F, Skeie GO, Aarli JA, Gilhus NE. Romi F, et al. Among authors: gilhus ne. Arch Neurol. 2000 Nov;57(11):1596-600. doi: 10.1001/archneur.57.11.1596. Arch Neurol. 2000. PMID: 11074791

6

Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.

Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA. Romi F, et al. Among authors: gilhus ne. Eur J Neurol. 2002 Jan;9(1):55-61. doi: 10.1046/j.1468-1331.2002.00352.x. Eur J Neurol. 2002. PMID: 11784377 Clinical Trial.

7

Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies.

Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA. Romi F, et al. Among authors: gilhus ne. Eur Neurol. 2003;49(4):210-7. doi: 10.1159/000070185. Eur Neurol. 2003. PMID: 12736536

8

Myasthenia gravis: consequences for pregnancy, delivery, and the newborn.

Hoff JM, Daltveit AK, Gilhus NE. Hoff JM, et al. Among authors: gilhus ne. Neurology. 2003 Nov 25;61(10):1362-6. doi: 10.1212/01.wnl.0000082725.21444.ec. Neurology. 2003. PMID: 14638956

9

Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.

Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA. Romi F, et al. Among authors: gilhus ne. Eur J Neurol. 2003 Nov;10(6):701-6. doi: 10.1046/j.1468-1331.2003.00678.x. Eur J Neurol. 2003. PMID: 14641516

10

Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.

Romi F, Skeie GO, Gilhus NE, Aarli JA. Romi F, et al. Among authors: gilhus ne. Arch Neurol. 2005 Mar;62(3):442-6. doi: 10.1001/archneur.62.3.442. Arch Neurol. 2005. PMID: 15767509 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters